Physician-Formulated · Evidence-Based

Protect Muscle.
Optimize GLP-1 Outcomes.

The clinical standard for muscle preservation during GLP-1 therapy. Physician-designed protocols that calculate sarcopenia risk and deliver actionable protection targets.

Real-time sarcopenia risk scoring
Personalised protein & fiber targets
Evidence-based supplement guidance
Continuous adherence monitoring

Trusted by clinicians

Used by physicians across Caribbean and North America

Grounded in NEJM, EWGSOP2, and 2026 clinical literature

GDPR and HIPAA-aligned data handling

Sarcopenia Risk Calculator

No account required · Clinical parameters · Results in seconds

4 fields remaining

Body metrics

GLP-1 therapy

Symptoms & lifestyle

GI symptoms on current dose
Select none if no symptomsGI burden directly impairs nutrient absorption and protein adequacy
Activity level *

Recovery environment

Recovery Environment Indicator (informational)
7hMild recovery deficit
4h6h7.5h9h

Sleep duration is displayed as a recovery context indicator. Nocturnal GH and IGF-1 secretion support muscle protein synthesis — adequate sleep optimises your protocol outcomes. This parameter is not incorporated into the sarcopenia risk score.

MyoGuard Clinical Oversight · For educational use only · Not a substitute for clinical consultation

Built on peer-reviewed evidence

NEJM · STEP 1 TrialDiabetes & Metabolism 2026Clinical Obesity · Urbina et al.EWGSOP2 Sarcopenia CriteriaJoint GLP-1 Advisory 2025